Business / Finance

RSS
Pieris, Zydus Cadila partner to develop and commercialize Anticalin-based protein therapeutics

Pieris, Zydus Cadila partner to develop and commercialize Anticalin-based protein therapeutics

16 Oct 2013
CEL-SCI, Ergomed To Co-Develop Head And Neck Cancer Candidate As Potential HPV Treatment

CEL-SCI, Ergomed To Co-Develop Head And Neck Cancer Candidate As Potential HPV Treatment

15 Oct 2013
Innate Immunotherapeutics moves operations over to Sydney, Australia

Innate Immunotherapeutics moves operations over to Sydney, Australia

15 Oct 2013
Marketing and technical support cooperation for aqueous acrylic enteric system, Acryl-EZE®, launched by Colorcon and Evonik Industries

Marketing and technical support cooperation for aqueous acrylic enteric system, Acryl-EZE®, launched by Colorcon and Evonik Industries

15 Oct 2013
immatics biotechnologies closes €34 million Series D financing round

immatics biotechnologies closes €34 million Series D financing round

15 Oct 2013
Colorcon, Evonik partner to market and support Acryl-EZE aqueous acrylic enteric system

Colorcon, Evonik partner to market and support Acryl-EZE aqueous acrylic enteric system

15 Oct 2013
St. Jude Medical completes Nanostim acquisition; leadless pacemaker receives CE Mark approval

St. Jude Medical completes Nanostim acquisition; leadless pacemaker receives CE Mark approval

15 Oct 2013
BioInvent extends license agreement with Bayer to develop antibodies

BioInvent extends license agreement with Bayer to develop antibodies

14 Oct 2013
Genentech plans to invest over $285M for expansion of biologics manufacturing facilities

Genentech plans to invest over $285M for expansion of biologics manufacturing facilities

14 Oct 2013
Affiliate of Channel Technologies Group buys assets of H.C. Materials

Affiliate of Channel Technologies Group buys assets of H.C. Materials

12 Oct 2013
Misonix terminates Product License and Distribution Agreement with PuriCore

Misonix terminates Product License and Distribution Agreement with PuriCore

12 Oct 2013
Auxilium Licenses Stendra From Vivus For Up To $300M

Auxilium Licenses Stendra From Vivus For Up To $300M

11 Oct 2013
Astrazeneca, Janssen To Promote Novel Prostate Cancer Treatment In Japan

Astrazeneca, Janssen To Promote Novel Prostate Cancer Treatment In Japan

11 Oct 2013
Novartis Inks Agreement For Immunogen's "TAP" ADC Technology

Novartis Inks Agreement For Immunogen's "TAP" ADC Technology

11 Oct 2013
Yale Launches Collaboration With ARO, CRO Partners

Yale Launches Collaboration With ARO, CRO Partners

11 Oct 2013
Yale Launches Collaboration With ARO, CRO Partners

Yale Launches Collaboration With ARO, CRO Partners

11 Oct 2013
Auxilium Licenses Stendra From Vivus For Up To $300M

Auxilium Licenses Stendra From Vivus For Up To $300M

11 Oct 2013
Astrazeneca, Janssen To Promote Novel Prostate Cancer Treatment In Japan

Astrazeneca, Janssen To Promote Novel Prostate Cancer Treatment In Japan

11 Oct 2013
Novartis Inks Agreement For Immunogen's "TAP" ADC Technology

Novartis Inks Agreement For Immunogen's "TAP" ADC Technology

11 Oct 2013
DePuy Synthes Spine expands collaboration with Brainlab

DePuy Synthes Spine expands collaboration with Brainlab

11 Oct 2013

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback